{"id":191851,"date":"2026-08-10T12:53:16","date_gmt":"2026-08-10T07:23:16","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=191851"},"modified":"2026-08-10T12:53:17","modified_gmt":"2026-08-10T07:23:17","slug":"pros-cons-investing-aartiind-share","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/pros-cons-investing-aartiind-share\/","title":{"rendered":"Aarti Industries Share: Pros and Cons Every Investor Must Know in 2026"},"content":{"rendered":"<div class=\"meta-block\"><\/div>\n<p style=\"border-left: 4px solid #1F4E79; background: #EBF3FB; padding: 10px 16px; font-style: italic;\"><em>Aarti Industries share CMP approx Rs 509. 52-week high Rs 650, low Rs 430. Market Cap Rs 18,140 Cr. P\/E ratio 34.16x.<\/em><\/p>\n<div style=\"background: #F0F7FF; border-left: 4px solid #1F4E79; border-radius: 6px; padding: 14px 18px; margin: 18px 0;\">\n<p style=\"margin: 0 0 8px 0; font-weight: bold; color: #1f4e79;\">Quick Answer<\/p>\n<ul style=\"margin: 0; padding-left: 20px; color: #333;\">\n<li>Aarti Industries share at 34.16x PE with 7.04% ROE \u2014 transition year reflecting subsidiary demerger and new capacity investment<\/li>\n<li>India&#8217;s largest toluene and benzene-based specialty chemical company with 1,000+ chemical products<\/li>\n<li>Key concern: ROE of 7.04% is very low \u2014 transition year from demerger and capacity investment compressing returns<\/li>\n<\/ul>\n<\/div>\n<p>Is the Aarti Industries share a good investment in 2026? This article provides a data-driven analysis of Aarti Industries share pros and cons \u2014 covering business strengths, valuation, growth drivers, and key risks \u2014 based on live data from 7 August 2026.<\/p>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&amp;utm_medium=aarti-industries-pros-cons\"><strong>Click Here \u2014 Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/pros-cons-investing-aartiind-share\/#About_Aarti_Industries\" title=\"About Aarti Industries\">About Aarti Industries<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/pros-cons-investing-aartiind-share\/#Key_Financial_Snapshot_Aarti_Industries_Share\" title=\"Key Financial Snapshot: Aarti Industries Share\">Key Financial Snapshot: Aarti Industries Share<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/pros-cons-investing-aartiind-share\/#Top_5_Pros_of_Aarti_Industries_Share\" title=\"Top 5 Pros of Aarti Industries Share\">Top 5 Pros of Aarti Industries Share<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/pros-cons-investing-aartiind-share\/#1_Indias_Largest_Benzene_Specialty_Chemical_Chain_%E2%80%94_Diversified_1000-Plus_Product_Portfolio\" title=\"1. India&#8217;s Largest Benzene Specialty Chemical Chain \u2014 Diversified 1,000-Plus Product Portfolio\">1. India&#8217;s Largest Benzene Specialty Chemical Chain \u2014 Diversified 1,000-Plus Product Portfolio<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/pros-cons-investing-aartiind-share\/#2_Long-Term_CRAMS-Like_Pharma_Specialty_Contracts_%E2%80%94_Sticky_Client_Relationships\" title=\"2. Long-Term CRAMS-Like Pharma Specialty Contracts \u2014 Sticky Client Relationships\">2. Long-Term CRAMS-Like Pharma Specialty Contracts \u2014 Sticky Client Relationships<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/pros-cons-investing-aartiind-share\/#3_Indias_China-Plus-One_Specialty_Chemical_Beneficiary_%E2%80%94_Supply_Chain_Diversification\" title=\"3. India&#8217;s China-Plus-One Specialty Chemical Beneficiary \u2014 Supply Chain Diversification\">3. India&#8217;s China-Plus-One Specialty Chemical Beneficiary \u2014 Supply Chain Diversification<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/pros-cons-investing-aartiind-share\/#4_Export_Revenue_From_60_Countries_%E2%80%94_Geographic_Revenue_Diversification\" title=\"4. Export Revenue From 60 Countries \u2014 Geographic Revenue Diversification\">4. Export Revenue From 60 Countries \u2014 Geographic Revenue Diversification<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/pros-cons-investing-aartiind-share\/#5_Pharma_Specialty_Demerger_%E2%80%94_Aarti_Pharmalabs_Creating_Focused_Pharma_Chemistry_Entity\" title=\"5. Pharma Specialty Demerger \u2014 Aarti Pharmalabs Creating Focused Pharma Chemistry Entity\">5. Pharma Specialty Demerger \u2014 Aarti Pharmalabs Creating Focused Pharma Chemistry Entity<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/pros-cons-investing-aartiind-share\/#Key_Cons_of_Aarti_Industries_Share\" title=\"Key Cons of Aarti Industries Share\">Key Cons of Aarti Industries Share<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/pros-cons-investing-aartiind-share\/#1_ROE_of_704_Percent_Very_Low_%E2%80%94_Transition_Year_From_Demerger_and_Capacity_Expansion\" title=\"1. ROE of 7.04 Percent Very Low \u2014 Transition Year From Demerger and Capacity Expansion\">1. ROE of 7.04 Percent Very Low \u2014 Transition Year From Demerger and Capacity Expansion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/pros-cons-investing-aartiind-share\/#2_Aarti_Pharmalabs_Demerger_Impact_%E2%80%94_Parents_Revenue_and_Margins_Reduced\" title=\"2. Aarti Pharmalabs Demerger Impact \u2014 Parent&#8217;s Revenue and Margins Reduced\">2. Aarti Pharmalabs Demerger Impact \u2014 Parent&#8217;s Revenue and Margins Reduced<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/pros-cons-investing-aartiind-share\/#3_Chinese_Specialty_Chemical_Competition_%E2%80%94_Aarti_Faces_Price_Pressure_in_Benzene_Derivatives\" title=\"3. Chinese Specialty Chemical Competition \u2014 Aarti Faces Price Pressure in Benzene Derivatives\">3. Chinese Specialty Chemical Competition \u2014 Aarti Faces Price Pressure in Benzene Derivatives<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/pros-cons-investing-aartiind-share\/#4_3416x_PE_Elevated_for_704_Percent_ROE_%E2%80%94_Transition_Year_Multiple_Distortion\" title=\"4. 34.16x PE Elevated for 7.04 Percent ROE \u2014 Transition Year Multiple Distortion\">4. 34.16x PE Elevated for 7.04 Percent ROE \u2014 Transition Year Multiple Distortion<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/pros-cons-investing-aartiind-share\/#Is_Aarti_Industries_Share_a_Good_Investment_in_2026\" title=\"Is Aarti Industries Share a Good Investment in 2026?\">Is Aarti Industries Share a Good Investment in 2026?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/pros-cons-investing-aartiind-share\/#Key_Risks_Before_Buying_Aarti_Industries_Share\" title=\"Key Risks Before Buying Aarti Industries Share\">Key Risks Before Buying Aarti Industries Share<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/pros-cons-investing-aartiind-share\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/pros-cons-investing-aartiind-share\/#Frequently_Asked_Questions_%E2%80%94_Aarti_Industries_Share\" title=\"Frequently Asked Questions \u2014 Aarti Industries Share\">Frequently Asked Questions \u2014 Aarti Industries Share<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/pros-cons-investing-aartiind-share\/#What_are_the_main_pros_of_Aarti_Industries_share\" title=\"What are the main pros of Aarti Industries share?\">What are the main pros of Aarti Industries share?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/pros-cons-investing-aartiind-share\/#What_are_the_risks_of_Aarti_Industries_share\" title=\"What are the risks of Aarti Industries share?\">What are the risks of Aarti Industries share?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/univest.in\/blogs-2\/pros-cons-investing-aartiind-share\/#Is_Aarti_Industries_share_a_good_investment\" title=\"Is Aarti Industries share a good investment?\">Is Aarti Industries share a good investment?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/univest.in\/blogs-2\/pros-cons-investing-aartiind-share\/#What_is_the_52-week_range_of_Aarti_Industries_share\" title=\"What is the 52-week range of Aarti Industries share?\">What is the 52-week range of Aarti Industries share?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-22\" href=\"https:\/\/univest.in\/blogs-2\/pros-cons-investing-aartiind-share\/#What_was_the_Aarti_Pharmalabs_demerger\" title=\"What was the Aarti Pharmalabs demerger?\">What was the Aarti Pharmalabs demerger?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-23\" href=\"https:\/\/univest.in\/blogs-2\/pros-cons-investing-aartiind-share\/#What_does_Aarti_Industries_produce\" title=\"What does Aarti Industries produce?\">What does Aarti Industries produce?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"About_Aarti_Industries\"><\/span><strong>About Aarti Industries<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Aarti Industries Limited (NSE: AARTIIND) is a Vapi-based specialty chemicals company founded in 1975. India&#8217;s largest benzene-based specialty chemical manufacturer, it produces 1,000-plus chemical products including nitrobenzene, chlorobenzene, sulphuric acid derivatives, and downstream specialty chemicals for agrochemical, pharmaceutical, polymer, and FMCG industries globally. Aarti Industries serves 700-plus global chemical companies across 60 countries.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Financial_Snapshot_Aarti_Industries_Share\"><\/span><strong>Key Financial Snapshot: Aarti Industries Share<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table>\n<thead>\n<tr>\n<th>Parameter<\/th>\n<th>Details<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Company<\/td>\n<td><a href=\"https:\/\/univest.in\/stocks\/aartiind\/aarti-industries-ltd-share-price-today\">Aarti Industries<\/a><\/td>\n<\/tr>\n<tr>\n<td>NSE Symbol<\/td>\n<td>AARTIIND<\/td>\n<\/tr>\n<tr>\n<td>Sector<\/td>\n<td>Specialty Chemicals Benzene<\/td>\n<\/tr>\n<tr>\n<td>CMP (Approx)<\/td>\n<td>Rs 509<\/td>\n<\/tr>\n<tr>\n<td>52-Week High<\/td>\n<td>Rs 650<\/td>\n<\/tr>\n<tr>\n<td>52-Week Low<\/td>\n<td>Rs 430<\/td>\n<\/tr>\n<tr>\n<td>Market Cap<\/td>\n<td>Rs 18,140 Cr<\/td>\n<\/tr>\n<tr>\n<td>P\/E Ratio<\/td>\n<td>34.16x<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><em>Data approximate. Verify at <a href=\"https:\/\/www.nseindia.com\" rel=\"nofollow noopener\" target=\"_blank\">nseindia.com<\/a>.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Top_5_Pros_of_Aarti_Industries_Share\"><\/span><strong>Top 5 Pros of Aarti Industries Share<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"1_Indias_Largest_Benzene_Specialty_Chemical_Chain_%E2%80%94_Diversified_1000-Plus_Product_Portfolio\"><\/span><strong>1. India&#8217;s Largest Benzene Specialty Chemical Chain \u2014 Diversified 1,000-Plus Product Portfolio<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Aarti Industries share represents India&#8217;s most comprehensive benzene chemistry value chain \u2014 from basic aromatic chemistry to specialty downstream products for agro, pharma, polymer, and FMCG industries. This diversified 1,000-plus product portfolio reduces exposure to any single product&#8217;s demand cycle.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"2_Long-Term_CRAMS-Like_Pharma_Specialty_Contracts_%E2%80%94_Sticky_Client_Relationships\"><\/span><strong>2. Long-Term CRAMS-Like Pharma Specialty Contracts \u2014 Sticky Client Relationships<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Aarti Industries serves global specialty chemical and pharmaceutical companies with long-term supply agreements for specific intermediates. These contracts provide multi-year revenue visibility and create high switching costs for clients who have qualified Aarti&#8217;s specific synthesis processes in their regulated manufacturing.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"3_Indias_China-Plus-One_Specialty_Chemical_Beneficiary_%E2%80%94_Supply_Chain_Diversification\"><\/span><strong>3. India&#8217;s China-Plus-One Specialty Chemical Beneficiary \u2014 Supply Chain Diversification<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Global chemical companies seeking to diversify away from Chinese specialty chemical dependency are increasingly qualifying Indian suppliers like Aarti Industries. As India&#8217;s China-plus-one chemical sourcing grows, Aarti&#8217;s diversified product range and scale position it as a preferred Indian specialty chemical alternative.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"4_Export_Revenue_From_60_Countries_%E2%80%94_Geographic_Revenue_Diversification\"><\/span><strong>4. Export Revenue From 60 Countries \u2014 Geographic Revenue Diversification<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Aarti Industries exports to 60-plus countries, providing revenue diversification across global chemical demand cycles. This geographic diversity reduces India-domestic cycle dependency and provides USD revenue that benefits during INR depreciation.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"5_Pharma_Specialty_Demerger_%E2%80%94_Aarti_Pharmalabs_Creating_Focused_Pharma_Chemistry_Entity\"><\/span><strong>5. Pharma Specialty Demerger \u2014 Aarti Pharmalabs Creating Focused Pharma Chemistry Entity<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Aarti Industries demerged its pharmaceutical chemicals business as Aarti Pharmalabs Limited, creating a focused specialty pharma chemistry entity. This demerger aims to unlock value by allowing pharma-focused investors to value the pharma chemistry business independently at pharmaceutical company multiples.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Cons_of_Aarti_Industries_Share\"><\/span><strong>Key Cons of Aarti Industries Share<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"1_ROE_of_704_Percent_Very_Low_%E2%80%94_Transition_Year_From_Demerger_and_Capacity_Expansion\"><\/span><strong>1. ROE of 7.04 Percent Very Low \u2014 Transition Year From Demerger and Capacity Expansion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>At 7.04% ROE with debt-to-equity of 0.83x, Aarti Industries share is significantly below quality specialty chemical benchmarks. The low ROE reflects the transition year after the Aarti Pharmalabs demerger (removing high-margin pharma chemistry from the parent) and new capacity investment that has increased capital employed without proportional revenue yet.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"2_Aarti_Pharmalabs_Demerger_Impact_%E2%80%94_Parents_Revenue_and_Margins_Reduced\"><\/span><strong>2. Aarti Pharmalabs Demerger Impact \u2014 Parent&#8217;s Revenue and Margins Reduced<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The demerger of Aarti Pharmalabs removed the high-margin pharma chemistry business from Aarti Industries&#8217; revenue. The parent company&#8217;s remaining benzene specialty portfolio has lower margins than the pharma chemistry business, compressing overall ROE and PE attractiveness temporarily.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"3_Chinese_Specialty_Chemical_Competition_%E2%80%94_Aarti_Faces_Price_Pressure_in_Benzene_Derivatives\"><\/span><strong>3. Chinese Specialty Chemical Competition \u2014 Aarti Faces Price Pressure in Benzene Derivatives<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Benzene-based specialty chemicals are a category where China has significant production scale. Chinese chlorobenzene and nitrobenzene manufacturers can undercut Aarti&#8217;s prices in standard-grade products, limiting Aarti&#8217;s ability to raise prices in the commodity chemistry segment of its portfolio.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"4_3416x_PE_Elevated_for_704_Percent_ROE_%E2%80%94_Transition_Year_Multiple_Distortion\"><\/span><strong>4. 34.16x PE Elevated for 7.04 Percent ROE \u2014 Transition Year Multiple Distortion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>At 34.16x PE with only 7.04% ROE, Aarti Industries share is expensive relative to current earnings quality. The investment thesis requires ROE to recover above 12 percent as transition effects normalise and new capacity generates full utilisation revenue.<\/p>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Use the Univest Screener to Analyse Stocks for Free<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Is_Aarti_Industries_Share_a_Good_Investment_in_2026\"><\/span><strong>Is Aarti Industries Share a Good Investment in 2026?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Aarti Industries share requires ROE recovery from current 7.04% levels before the 34.16x PE is comfortable. The China-plus-one tailwind and long-term specialty chemical contracts are genuine positives. Consider after ROE recovery evidence above 12 percent.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks_Before_Buying_Aarti_Industries_Share\"><\/span><strong>Key Risks Before Buying Aarti Industries Share<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>Aarti Pharmalabs demerger taking longer to stabilise than expected keeping parent ROE suppressed<\/li>\n<li>Chinese specialty chemical dumping in benzene derivatives further compressing Aarti&#8217;s margins<\/li>\n<li>New chemical capacity utilisation ramp-up slower than guided extending the transition period<\/li>\n<li>Global agrochemical and polymer demand slowdown reducing specialty chemical order volumes<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The Aarti Industries share offers india&#8217;s largest benzene specialty chemical chain \u2014 diversified 1,000-plus product portfolio as its primary investment case. Weigh it against roe of 7.04 percent very low \u2014 transition year from demerger and capacity expansion and the risks above before investing. Use the Univest Screener and consult a SEBI-registered advisor.<\/p>\n<p style=\"margin-top: 24px;\"><em>Download the <a href=\"https:\/\/apps.apple.com\/in\/app\/univest-stock-market-research\/id1576403520\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"https:\/\/play.google.com\/store\/apps\/details?id=com.univest.stockmarket\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Aarti Industries share price live.<\/em><\/p>\n<div style=\"background: #CC0000; border-radius: 8px; padding: 16px 20px; margin: 24px 0;\">\n<p style=\"color: #ffffff; font-size: 13px; line-height: 1.7; margin: 0;\"><strong style=\"color: #ffffff;\">Disclaimer:<\/strong> Data from publicly available sources. Approximate as of 7 Aug 2026. Verify on nseindia.com and bseindia.com. Not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions_%E2%80%94_Aarti_Industries_Share\"><\/span><strong>Frequently Asked Questions \u2014 Aarti Industries Share<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_main_pros_of_Aarti_Industries_share\"><\/span><strong>What are the main pros of Aarti Industries share?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> India&#8217;s largest benzene specialty chemical chain with 1,000-plus diversified products, long-term CRAMS-like pharma specialty contracts with sticky client relationships, India&#8217;s China-plus-one beneficiary for specialty chemical supply diversification, 60-country export revenue diversification, and Aarti Pharmalabs demerger potentially unlocking value.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_risks_of_Aarti_Industries_share\"><\/span><strong>What are the risks of Aarti Industries share?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> ROE of 7.04% very low from demerger and capacity expansion transition, Aarti Pharmalabs demerger removing high-margin pharma chemistry from parent, Chinese benzene derivative price competition, and 34.16x PE elevated for current ROE requiring recovery above 12%. Wait for ROE improvement evidence.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Aarti_Industries_share_a_good_investment\"><\/span><strong>Is Aarti Industries share a good investment?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Consider after ROE recovery above 12% from transition normalisation. Currently transition-year. Consult a SEBI-registered advisor. Not investment advice.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_52-week_range_of_Aarti_Industries_share\"><\/span><strong>What is the 52-week range of Aarti Industries share?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> 52-week high approximately Rs 650, low Rs 430. Verify at nseindia.com.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_was_the_Aarti_Pharmalabs_demerger\"><\/span><strong>What was the Aarti Pharmalabs demerger?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Aarti Industries demerged its pharmaceutical specialty chemical business \u2014 manufacturing pharmaceutical intermediates, APIs, and specialty pharma chemicals for global drug companies \u2014 as Aarti Pharmalabs Limited (separately listed). The rationale was that pharma chemistry commands higher valuation multiples (40 to 60x PE) than commodity benzene derivatives (15 to 25x PE). By creating a focused pharma entity, Aarti aimed to let each business be valued at its own appropriate sector multiple rather than the blended conglomerate discount.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_does_Aarti_Industries_produce\"><\/span><strong>What does Aarti Industries produce?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Aarti Industries produces across categories: Benzene-based aromatics (chlorobenzene, nitrobenzene, aniline), Sulphuric acid derivatives (oleum, chloro-sulphuric acid), Hydrogenation products (cyclohexylamine, dicyclohexylamine), Polymer intermediates (ABS precursors, specialty monomers), Agrochemical intermediates (herbicide, fungicide building blocks), and Performance chemicals for FMCG, personal care, and textile processing. Each category serves different downstream industry verticals across India and 60 export countries.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Aarti Industries share pros and cons: India&#8217;s largest benzene specialty chemical company at 34x PE during transition-year ROE depression analysed for 2026.<\/p>\n","protected":false},"author":28,"featured_media":191850,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[3802],"class_list":["post-191851","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["191850"],"_edit_lock":["1786346600:28"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["842"],"rank_math_seo_score":["78"],"rank_math_title":["Aarti Industries Share Pros and Cons 2026 | AARTIIND Specialty Chemicals Analysis"],"rank_math_description":["Aarti Industries share pros and cons: India's largest benzene-based specialty chemical company at 34.16x PE with 7.04% ROE versus transition year earnings compression and China competition."],"rank_math_focus_keyword":["Aarti Industries Share"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"_edit_last":["28"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["35378"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/08\/pros-cons-investing-aartiind-share.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/191851","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/28"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=191851"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/191851\/revisions"}],"predecessor-version":[{"id":193570,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/191851\/revisions\/193570"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/191850"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=191851"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=191851"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=191851"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}